ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01229150
Brief Title: Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...

First Submitted : October 26, 2010
First Submitted that Met QC Criteria : October 26, 2010
First Posted : October 27, 2010 (Estimate)

Results First Submitted : October 23, 2014
Results First Submitted that Met QC Criteria : October 23, 2014
Results First Posted : October 29, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 17, 2017
Last Update Posted : May 23, 2017